Durability of Vaccine Efficacy Against SARS-CoV-2 Infection
Description
Implements a nonparametric maximum likelihood method for assessing
potentially time-varying vaccine efficacy (VE) against SARS-CoV-2 infection
under staggered enrollment and time-varying community transmission, allowing
crossover of placebo volunteers to the vaccine arm.
Lin, D. Y., Gu, Y., Zeng, D., Janes, H. E., and Gilbert, P. B. (2021)
.